CFGS
UROV

Concourse Financial Group Securities’s Urovant Sciences Ltd. UROV Stock Holding History

Concourse Financial Group Securities’s Portfolio UROV Stock Details UROV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,250
Closed -$20K – 2461
2020
Q4 		$20K Hold
1,250
– – ﹤0.01% 1471
2020
Q3 		$12K Buy
+1,250
New +$11.1K ﹤0.01% 1533

Concourse Financial Group Securities's UROV Position: Q1 2021 in Review

Concourse Financial Group Securities sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 1,250 shares — an estimated $20K sold.

Concourse Financial Group Securities first reported a position in UROV in Q3 2020 and held it in 2 quarters. The position peaked at $20K in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

  • Concourse Financial Group Securities reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
  • Concourse Financial Group Securities sold 1,250 Urovant Sciences Ltd. shares in Q1 2021, an estimated $20K.
  • Concourse Financial Group Securities first reported a position in Urovant Sciences Ltd. in Q3 2020 and held it in 2 quarters.
  • Concourse Financial Group Securities's Urovant Sciences Ltd. position peaked at $20K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Concourse Financial Group Securities's 13F filing for Q1 2021, filed 13 May 2021.